This work consists of two parts. In the first part, the doses in the human lung per unit exposure to thoron progeny, the dose conversion factor (DCF), was calculated. Dependence of the DCF on various environmental and subject-related parameters was investigated. The model used in these calculations was based on ICRP 66 recommendations. In the second part, the human lungs were considered as the source of beta and gamma radiation which target the other organs of the human body. The DCF to other organs was obtained as 20 mSv WLM -1 , which is larger than the DCF for radon progeny, which was 13 mSv WLM -1 . This is a consequence of the longer half-life of the relevant thoron progeny than that of the radon progeny. It is interesting to note that after the lungs, where the radiation source is actually located, muscle tissue receives the largest dose.
INTRODUCTION
Thoron, 220 Rn, is a radon isotope which decays by emission of an alpha particle with energy of 6.29 MeV, with a half-life of 55 s. Like radon, thoron due to its chemical inertness can migrate from soil into the atmosphere. In dwellings and closed spaces with poor ventilation accumulation of thoron and its progeny is possible, depending on the strength of the source (1) . The decay products consist of a variety of nuclides and each of them may be attached to aerosols of varying sizes. The unattached fraction typically comprises only around 2 % of the total activity.
Many dosimetric studies were carried out in order to determine the level of human exposure from inhaled radon, thoron and their progenies. These studies considered doses from short-lived progeny which emit alpha particles. However, other types of radiation, beta and gamma, are also present and contribute to the total dose, not only to the lung. 212 Pb and 212 Bi are short-lived thoron progeny, which decay by emitting beta particles accompanied by gamma radiation. The contribution of beta and gamma radiation from nuclides deposited in the lungs is not only to the lungs but to all other organs of the human body.
METHODOLOGY
In order to determine the dose per unit exposure, which is usually called the dose conversion factor (DCF), it is necessary to transform the dose per particle of radiation into the dose per unit exposure. To do that, the equilibrium activities of nuclides in the lungs per unit exposure are required. These data were obtained using the program LUNGDOSE, which was developed earlier for 222 Rn and described in a previous publication (2) , and hence that a detailed description will not be given here. In this program, the concepts introduced in ICRP 66 publication (3) were adopted. Since the decay schemes and alpha energies are different in the 222 Rn and 220 Rn series, the program LUNGDOSE was modified to take into account these differences. Modifications in the LUNGDOSE program performed in order to calculate the DCF for thoron progeny have already been described (4) . The input parameters for the program LUNGDOSE have been changed within reasonable ranges with different steps in different cases, whereas the other parameters have been kept at their best estimates, as is shown in Table 1 (a). DCFs were calculated for each of these sampled combinations and results are presented below.
In the second part of the work, all parameters were taken on their best estimates, which correspond to the adult Caucasian male, as given in Table 1 (a). On the basis of these parameters, equilibrium activities of thoron progeny were calculated in regions of the respiratory tract and are presented in Table 2 , respectively (also obtained with the LUNGDOSE program (2) ). Using data for activities, A n , yields, Y n R , of radiation and the mean absorbed dose per particle of radiation,D 
Further, the equivalent dose H T in some organ T was obtained as
where w R is the radiation weighting factor whose values for b 2 and g radiation are equal to 1. Summation per nuclide n was done to include contributions from both 212 Pb and 212 Bi. After obtaining the equivalent dose for the organs and remainder tissue for both males and females, the effective dose was calculated as
with H T;m as the equivalent dose for the male and H T;f for the female phantom; w T are tissue weighting factors taken from the new ICRP 103 recommendations (5) . In order to determine doses in organs of the human body due to sources of radiation placed in the lungs, a mathematical model of the human body known as the Oak Ridge National Laboratory (ORNL) phantom (6) was used together with Monte Carlo Neutron Particle (MCNP transport) software (7) , which enables simulation of radiation transport and interaction with matter in arbitrary geometries.
RESULTS AND DISCUSSION

DCF as a function of input parameters
The DCF-L (L is for lung) for thoron progeny depends on the blood transfer rate. This dependence is shown in Figure 1 . As expected, the DCF increases with the half-life of transfer to blood from 1 to about 6 mSv WLM -1 . Slower transport from lung to blood means a longer retention time in the lungs, which causes a larger lung dose.
The unattached aerosol size, expressed as AMTD, was varied from 0 to 3.5 nm. As shown in Figure 2 Figure 4 and coarse mode (from 1000 nm up to 4000 nm), Figure 5 . Dependence of DCF to the shape factor was also calculated and presented in Figure 6 , where can be seen that DCF is almost independent on the shape factor of nucleation and unattached modes, while it slowly decreases with the shape factor of coarse and accumulation modes.
Dependence of the DCF on the hygroscopic growth factor is shown in Figure 7 . The DCF varys with the hygroscopic factor, but the dependence is different for various modes. Dependence is most pronounced for the nucleation mode, where it increases from 5.4 up to almost 5.8 mSv WLM -1 . Finally in Figure 8 dependence of the DCF on the unattached fraction is presented. Linear dependence is found, and the equation of fit line is presented in the legend of the figure.
If all parameters were kept at their best estimates, a DCF of 4.5 mSv WLM -1 would be obtained.
Doses in other organs due to the beta and gamma radiation emitted by thoron progeny in the lung Doses in all the main organs and remainder tissue of the human body from beta and gamma progeny are calculated as described above and shown in Table 1 (b). It can be seen from Table 1 (b) that the absorbed dose is the largest in the lung, which is expected, since the source is in the lung itself. It is interesting to note that the dose in the remainder tissue is larger than doses in all main organs. According to ICRP 103 Publication (5) , the tissue weighting factor for the remainder tissues (0.12) applies to the arithmetic mean dose of the 13 organs and tissues for each sex. These organs are: adrenals, extra thoracic region, gall bladder, heart, kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, prostate (for male), small intestine, spleen, thymus and uterus/cervix (for female). After detailed investigation of doses in these organs, it is concluded that the largest contribution to dose the in the remainder tissue is to muscle. The absorbed dose from beta particles in muscle is 3.49, 4.01, 31.58 and 35.69 (mGy WLM -1 ) for 
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212 Pb male, 212 Pb female, 212 Bi male and 212 Bi female, respectively. Muscles were regarded as the soft tissue of the body minus the skeletal system and all the organs identified in the phantom. The large dose in this tissue can be explained by the fact that muscle tissue surrounds lungs and is directly exposed to radiation.
The effective dose, calculated using Equation (3), is 20.45 mSv WLM -1 .
CONCLUSION
The DCF value for best estimates agrees with the results from the literature. Parameter variation in this work induces DCF variation from 1 to 6 mSv WLM -1 , Table 1 (a). . This value is quite large when compared with the effective dose from beta and gamma emitting radon progeny 214 Pb and 214 Bi which is 13.4 mSv WLM -1 (8) . At a first glance this could look strange, since activities of radon progenies are quite larger than those from thoron. For beta-emitting radon progeny, the total activity in the lung is 958.2 Bq WL -1 , whereas for thoron it is 16.41 Bq WL -1 . This discrepancy can be overcome when regarding spectrums of radon and thoron progeny (8) . The thoron progenies 212 Pb and 212 Bi emit beta and gamma particles with higher energy than radon progeny and deliver higher doses, which when calculated per unit exposure result in a greater DCF. 
